9,672 results found

The United States Court of Appeals for the Ninth Circuit recently upheld a district court’s finding that a consummated hospital-physician group merger violated Section 7 of the Clayton Act.

For a succinct analysis of 1H 2024 venture investment and exit activity in life sciences and health care, take a look at HSBC's Venture Healthcare Report...

It is all about revenue! After a banner year for health stocks and private equity investors, it is possible that the Republican controlled Congress could create problems for new emerging health care technologies and new health care delivery models.

Private equity investment in healthcare and life sciences is evolving as investors prioritize high-quality, scalable assets with strong management teams in sectors resistant to technological disruption.

McGuireWoods partner and host invites Government Investigations & White Collar Litigation partners and to discuss compliance and regulatory challenges...

Teva Pharmaceutical Industries has entered into a strategic licensing agreement with Samsung Bioepis to commercialize two FDA-approved biosimilar products in the United States market. The agreement covers RENFLEXIS, a biosimilar to REMICADE for treating inflammatory conditions, and ETICOVO, a biosimilar to ENBREL for autoimmune diseases. Under the partnership structure, Samsung Bioepis will maintain regulatory oversight and manufacturing responsibilities while Teva leads U.S. commercialization efforts, with

In the premiere episode of The Professor's Corner, McGuireWoods partner David Pivnick shared best board practices to mitigate risk when making challenging...

In this episode of the TMA Chicago Midwest podcast, Sandy Prabhakar, managing director at Armory, shares insights from his more than 20 years of experience.

Mergers and acquisitions by multinational companies require attention to foreign investment controls around the world, and such controls vary widely.

It's been a busy few months since we announced our proposed merger with Allen & Overy. The response has been overwhelmingly positive from clients, employees and the wider legal community...

Foley & Lardner LLP Partner Louis Lehot was recently featured on Richard Hsu's podcast, "Untied," discussing his progression as a corporate, business, and technology lawyer in Silicon Valley.

One of the consequences of the proliferation of new data protection laws going into effect around the world is that every deal today is a ‘data deal' in some respects.

According to a Preqin report (reg. req.), 74% of investors in alternatives believe equity markets are at a peak, up from 61% at the end of 2018, and 6% believe markets are expanding

This article discusses the European Court of Justice's (ECJ) March 14, 2019 ruling (file no. C-724/17) on antitrust liability in M&A transactions.

Europe saw a major increase in public M&A activity in 2021, fueled by cheap money and optimism as economies started to emerge from the worst effects of the pandemic.

The new guidelines will replace previous guidelines published by the ESAs' predecessors.

A&M Global Transaction Advisory Group's Managing Directors, Steven Lee and Manish Gupta, were recently featured in the January–February issue of Board Leadership.